Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
✍ Scribed by Andrea Frilling; Rainer Görges; Karsten Tecklenborg; Peter Gaßmann; Maximilian Bockhorn; Malte Clausen; Christoph Erich Broelsch
- Book ID
- 117849354
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 350 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0039-6060
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa
## Abstract Differentiated thyroid carcinoma (DTC) is associated with prolonged natural history, and even recurrent tumor is not necessarily followed by increased mortality. Prognostic factors and different treatment strategies, therefore, are difficult to assess. One hundred and fifty‐seven patien
## Abstract ## BACKGROUND The follow‐up of patients with differentiated thyroid carcinoma (DTC) is traditionally carried out with ^131^I whole body scan (^131^I WBS) and serum thyroglobulin (Tg) measurement. Neck ultrasonography (US) is also used. ## METHODS We compared the roles of Tg measureme